Differences in vulnerability between health workers and the general population: Is volunteer selection required for COVID-19 control in Nigeria?

Differences in vulnerability between health workers and the general population: Is volunteer selection required for COVID-19 control in Nigeria?

As of November 8th 2020, the prevalence of the COVID-19 infection in Nigeria is 9.3% while the cumulative fatality rate was 1.8%.Health care workers play important roles in controlling pandemics. However, their health status determines to a great extent thestability or vulnerability of a health system. The stress accruing from high patient flow amidst scarcity of healthcare resourcesmay impact on their health negatively. Stress and lack of a good diet plan may facilitate the development of some diseases suchas hypertension (HTN), diabetes mellitus (DM), chronic kidney disease (CKD) and cardiovascular diseases (CVD). These diseasesare confirmed correlates of COVID-19 morbidity and fatality. Despite the high awareness of preventive healthcare services amonghealth workers (65%), the prevalence of these diseases are high due to low treatment and control. Although the pooled prevalenceof HTN and DM were lower among health workers than the in general population (22.0% vs 37.8% and 6.5% vs 8.1%, respectively),the prevalence of pre-HTN and pre-DM were higher in health workers than in the general population (35.1% vs 22.3% and 19.4% vs5.9%, respectively). Some of these diseases go undiagnosed until their late stages. Thus, increasing their vulnerability to COVID-19.To prevent controllable fatalities, health workers should be screened before they are engaged in the treatment of COVID-19 patients,irrespective of their previous medical history. Simultaneous testing for comorbidities and COVID-19 should also be carried out in thegeneral population, especially for high-risk groups to prevent future vulnerabilities to communicable diseases.

___

  • 1. World Health Organization (WHO). Rolling Updates on Coronavirus disease (COVID-19). https:www.who. int/emergencies/disease/novel-coronavirus-2019/ events-as-they-happen. Accessed 23/03/2020
  • 2. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and metaanalysis, Int J Infect Dis 2020.
  • 3. Sun P, Qie S, Liu Z, et al. Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection. J Med Virol 2020;92:612-7.
  • 4. Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New Eng J Med 2020;382:1708-20.
  • 5. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA 2020;323:1061-9.
  • 6. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-42.
  • 7. Nigeria Centre for Disease Control: COVID-19 Nigeria https://covid19.ncdc.gov.ng/ Accessed 13/11/2020.
  • 8. Gilbert M, Pullano G, Pinotti F, et al. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. Lancet 2020;395:871- 7.
  • 9. Egbi OG, Rotifa S, Jumbo J. Prevalence of hypertension and its correlates among employees of a tertiary hospital in Yenagoa, Nigeria. Ann Afr Med 2015;14:8- 17.
  • 10. Owolabi AO, Owolabi MO, Olaoloru AD, et al. Hypertension prevalence and awareness among a health workforce in Nigeria. Int J Med Update 2015; 10:9-10.
  • 11. Sumaila FG, SHittu A, Idris AS. Prevalence of undiagnosed hypertension and its associated risk factors among healthcare workers of some selected hospitals in Dutse, Jigawa state, north western Nigeria. Adv Sci Med 2016;1:19-23.
  • 12. Owolabi AO, Owolabi MO, Olaolorun AD, et al. Work related stress perception and hypertension amongst health workers of a mission hospital in Oyo State, south-western Nigeria. Afr J Prm Health Care Fam Med 2012;4:307.
  • 13. Onyemelukwe OU, Mamza AA, Suleiman YK, et al. Prevalence of Pre-Diabetes, Diabetes and Associated Cardiovascular Risk Amongst Healthcare Workers in Ahmadu Bello University Teaching Hospital (ABUTH), Zaria using Glycated Haemoglobin. West Afr J Med 2020;37:91-9.
  • 14. Hsu CC, Brancati FL, Astor BC, et al. Blood pressure, atherosclerosis, and albuminuria in 10,113 participants of the Atherosclerosis Risk in Communities (ARIC) study. J Hypertens 2009;27:397-409.
  • 15. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003;289:2560-72.
  • 16. Oluyombo R, Olamoyegun MA, Olaifa O, et al. Cardiovascular risk factors in semi-urban communities in southwest Nigeria: Patterns and prevalence. J Epidemiol Global Health 2015;5:167-74.
  • 17. Olamoyegun MA, Oluyombo R, Iwuala SO, et al. Epidemiology and patterns of hypertension in semi-urban communities, south-western Nigeria. Cardiovasc J Afr 2016;27:356-60.
  • 18. Akpan EE, Ekrikpo UE, Udo AIA. Risk Factors for Chronic Kidney Disease in Urban Uyo, South-South, Nigeria. Saudi J Kidney Dis Transpl 2016;27:1011-7.
  • 19. Akinbodewa AA, Adejumo AO, Koledoye OV, et al. Community screening for prehypertension, traditional risk factors and markers of chronic kidney diseasein Ondo State, South-Western Nigeria. Niger Postgrad Med J 2017;24:25-30.
  • 20. Okwuonu CG, Chukwuonye II, Adejumo OA, et al. Prevalence of chronic kidney disease and its risk factors among adults in a semi-urban community of South-East Nigeria. Niger Postgrad Med J 2017;24:81- 7.
  • 21. Dokunmu TM, Yakubu OF, Adebayo AH, et al. Cardiovascular Risk Factors in a Suburban Community in Nigeria. Int J Hypertens 2018; 6898527.
  • 22. Okoye OCA, Oviasu E, Ojogwu L. Prevalence of Chronic Kidney Disease and Its Risk Factors amongst Adults in a Rural Population in Edo State, Nigeria. J US-China Med Sci 2011;8:471-81.
  • 23. Isara AR, Okundia PO. The burden of hypertension and diabetes mellitus in rural communities in southern Nigeria. Pan Afr Med J 2015;20:103.
  • 24. Okafor UH, Ahmed S, Unuigbe EI. Screening for risk factors of chronic kidney disease in a community in Niger Delta Nigeria. Ann Afr Med 2015;14:137-42.
  • 25. Oguoma VM, Nwose EU, Skinner TC, et al. Prevalence of cardiovascular disease risk factors among a Nigerian adult population: relationship with income level and accessibility to CVD risks screening. BMC Public Health. 2015;15:397.
  • 26. Ulasi II, Ijoma CK. The Enormity of Chronic Kidney Disease in Nigeria: The Situation in a Teaching Hospital in South-East Nigeria 2010;2010.
  • 27. Odili AN, Abatta EO. Blood pressure indices, life-style factors and anthropometric correlates of casual blood glucose in a rural Nigerian community. Ann Afr Med 2015;14:39-45.
  • 28. Obinna CO, Elias CA, Nkeiru PO. Screening for Hypertension and Diabetes in an Underserved Population through Community Outreach; A Case of Rural Community in Enugu State, Nigeria. Asian J Med Health 2019;15:1-9.
  • 29. Chukwuonye II, Ohagwu KA, Adelowo OO, et al. Prevalence and Predictors of Chronic Kidney Disease in a Semiurban Community in Lagos. Int J Nephrol 2019;2019.
  • 30. Mukadas AO, Misbau U. Incidence and patterns of cardiovascular disease in north western Nigeria. Niger Med J 2009;50:55-7.
  • 31. Nalado AM, Abdu A, Muhammad H, et al. Prevalence of risk factors for chronic kidney disease among civil servants in Kano. Niger J Basic Clin Sci 2012;9:70-4.
  • 32. Makusidi MA, Liman HM, Yakubu, et al. Prevalence of Non-communicable Diseases and its Awareness among Inhabitants of Sokoto Metropolis: Outcome of a Screening Program for Hypertension, Obesity, Diabetes Mellitus and Overt proteinuria. Arab J Nephrol Transplant 2013;6:189-91.
  • 33. Bello-Ovosi BO, Asuke S, Abdulrahman SO, et al. Prevalence and correlates of hypertension and diabetes mellitus in an urban community in North- Western Nigeria. Pan Afr Med J 2018;29:1-7.
  • 34. Adedapo AD. Rising trend of cardiovascular diseases among South-Western Nigerian female patients. Nig J Cardiol 2017;14:71-4.
  • 35. Ukpabi OJ, Uwanurochi K. Comparing indications for cardiovascular admissions into a Nigerian and an Israeli Hospital. Ann Afr Med 2017;16:70-3.
  • 36. Nwatu CB, Young EE, Okwara CC, et al. Concurrent Prediabetes and Prehypertension in a Rural Community in South East Nigeria. J Adv Med Med Res 2017;22:1-10.
  • 37. Iloh GUP, Uchenna NR, Obiegbu NP. Risk factors of pre-diabetes among adult Nigerians with essential hypertension in a resource-constrained setting of a primary care clinic in Eastern Nigeria 2013;1:56-64.
  • 38. Garber AJ, Handelsman Y, Einhorn D, et al. Diagnosis and management of prediabetes in the continuum of hyperglycaemia – when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract 2008;14:933- 46.
  • 39. Wokoma FS, Emem-chioma P, Oko-Jaja RI. Systematic analysis of community studies of risk factors and prevalence of CKKD in Nigeria (2006-2014). Trop J Nephrol 2016;11:7-16.
  • 40. Adeniyi BO, Awokola BI, Irabor I, et al. Pattern of Respiratory Disease Admissions among Adults at Federal Medical Centre, Owo, South-West, Nigeria: A 5-Year Review. Ann Med Health Sci Res 2017;7:96- 101.
Annals of Medical Research-Cover
  • Yayın Aralığı: Aylık
  • Yayıncı: İnönü Üniversitesi Tıp Fakültesi
Sayıdaki Diğer Makaleler

From the point of view of a gastroenterologist: Is the ulcer malign, or benign?

Serkan CERRAH, Ahmed Ramiz BAYKAN, Emre GERÇEKER, Sedat ÇİFTEL

Differences in vulnerability between health workers and the general population: Is volunteer selection required for COVID-19 control in Nigeria?

Jude Ogechukwu OKOYE

Labor and birth outcomes in term low-risk adolescent pregnancies

Şevki ÇELEN, Ümit Yasemin SERT DİNÇ, Gül Nihal BÜYÜK, Mete Can ATEŞ, Hasan Onur TOPÇU, Zeynep Aslı OSKOVİ KAPLAN

Dermatofibrosarcoma protuberans: An unusual case of breast

Kazım GEMİCİ, Ramazan GÜNDOĞDU

Neonatal COVID-19 case from Turkey; a Case report of neonatal

İsmail Kürşad GÖKÇE, Mehmet Fatih DEVECİ, Ramazan ÖZDEMİR

How can clinically-safe and effective Platelet Rich Plasma (PRP) be obtained in a laboratory?

Recep Onur KARABACAK, Latife ATASOY KARAKAŞ, Derya DENİZ ERCAN, Esra KARABAY, Seyhan GÜMÜŞLÜ

The impact of tumor localization on prognosis of the patients following liver transplantation for hepatocellular carcinoma

Talha SARIGÖZ, Tevfik Tolga ŞAHİN, Adil BAŞKIRAN, Volkan İNCE, Sertaç USTA

Evaluation of the compatibility of clinical primary diagnoses with mri reports in patients with temporomandibular disc displacement

Saim YANIK, Mevlüde POLAT

The effect of growth hormone deficiency on inflammatory markers in Sheehan's syndrome

Ayşegül SAKİN, Saliha YILDIZ, Murat ALAY, Gülçin Miyase SÖNMEZ

A rare case of rhinosinusitis: Three different complications in a patient

Erdoğan OKUR, Mehmet Emre SİVRİCE, Hasan YASAN, Yusuf Çağdaş KUMBUL, Sarper SAYIN